Peptic ulcer disease endoscopy: Difference between revisions

Jump to navigation Jump to search
Line 28: Line 28:
{{familytree | | C01 | | | | | C02 | | | | | C03 |C01=Active bleeding<br>or non-bleeding<br> visible vessel |C02=Adherent clot |C03=Flat spot<br> or clean base}}
{{familytree | | C01 | | | | | C02 | | | | | C03 |C01=Active bleeding<br>or non-bleeding<br> visible vessel |C02=Adherent clot |C03=Flat spot<br> or clean base}}
{{familytree | | |!| | | | | | |!| | | | | | |!| |}}
{{familytree | | |!| | | | | | |!| | | | | | |!| |}}
{{familytree | | D01 | | | | | D02 | | | | | D03 |D01=Endoscopic therapies<br> Injection therapy<br>|D02=D02|D03=D03}}
{{familytree | | D01 | | | | | D02 | | | | | D03 |D01=Endoscopic therapies:<br>•Injection therapy<br>|D02=D02|D03=D03}}
{{familytree | | |!| | | | | | |!| | | | | | |!|}}
{{familytree | | |!| | | | | | |!| | | | | | |!|}}
{{familytree | | |`|-|-|-|-|-|-|+|-|-|-|-|-|-|'|}}
{{familytree | | |`|-|-|-|-|-|-|+|-|-|-|-|-|-|'|}}

Revision as of 19:42, 7 November 2017

Peptic ulcer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peptic Ulcer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Upper GI Endoscopy

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Endoscopic management
Surgical management

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

2017 ACG Guidelines for Peptic Ulcer Disease

Guidelines for the Indications to Test for, and to Treat, H. pylori Infection

Guidelines for First line Treatment Strategies of Peptic Ulcer Disease for Providers in North America

Guidlines for factors that predict the successful eradication when treating H. pylori infection

Guidelines to document H. pylori antimicrobial resistance in the North America

Guidelines for evaluation and testing of H. pylori antibiotic resistance

Guidelines for when to test for treatment success after H. pylori eradication therapy

Guidelines for penicillin allergy in patients with H. pylori infection

Guidelines for the salvage therapy

Peptic ulcer disease endoscopy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peptic ulcer disease endoscopy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peptic ulcer disease endoscopy

CDC on Peptic ulcer disease endoscopy

Peptic ulcer disease endoscopy in the news

Blogs on Peptic ulcer disease endoscopy

to Hospitals Treating Peptic ulcer

Risk calculators and risk factors for Peptic ulcer disease endoscopy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

Endoscopic therapy

Indications for endoscopic therapy

  • Patients with active spurting or oozing bleeding or a non-bleeding visible vessel[1]
  • Patients with an adherent clot resistant to vigorous irrigation

Endoscopic therapy can be done by following methods:[2]

  • Injection therapy:
    • Injection of diluted epinephrine (1:10,000) is commonly used[3]
    • injection of sclerosant (eg polidocanol, ethanolamine, and ethanol), fibrin sealant, and n-butyl cyanoacrylate [4][5][6]
  • Thermal coagulation:
    • Contact types -heater probe, monopolar and bipolar electrocoagulation
    • Noncontact types -laser treatment, argon plasma coagulation [APC][7]
  • Mechanical Devices-Endoclips and band ligation are used commonly[8][9]
  • Combined Therapy-injection of diluted epinephrine followed by thermal coagulation[7]
  • Hemospray: nanopowder with clotting abilities is sprayed onto the bleeding site.[10]

Endoscopic therapy and Medical therapy for bleeding ulcer

 
 
 
 
 
 
 
 
Bleeding ulcer
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Endoscopy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Active bleeding
or non-bleeding
visible vessel
 
 
 
 
Adherent clot
 
 
 
 
Flat spot
or clean base
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Endoscopic therapies:
•Injection therapy
 
 
 
 
D02
 
 
 
 
D03
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E01
 
 
 
 
 

Second look endoscopy

  • Second look endoscopy is used to detect and retreat ulcers that are at risk of recurrent bleeding which reduces the number of episodes of recurrent bleeding and hence decrease the surgery necessary to treat recurrent bleeding[11][12]
  • It is usually done after 24 hours.

If bleeding occurs after a second endoscopic therapeutic session, surgery or interventional radiology with transcatheter arterial embolization is done.

References

  1. Laine L, McQuaid KR (2009). "Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials". Clin. Gastroenterol. Hepatol. 7 (1): 33–47, quiz 1–2. doi:10.1016/j.cgh.2008.08.016. PMID 18986845.
  2. Cook DJ, Guyatt GH, Salena BJ, Laine LA (1992). "Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis". Gastroenterology. 102 (1): 139–48. PMID 1530782.
  3. Park CH, Lee SJ, Park JH, Park JH, Lee WS, Joo YE, Kim HS, Choi SK, Rew JS, Kim SJ (2004). "Optimal injection volume of epinephrine for endoscopic prevention of recurrent peptic ulcer bleeding". Gastrointest. Endosc. 60 (6): 875–80. PMID 15605000.
  4. Rutgeerts P, Rauws E, Wara P, Swain P, Hoos A, Solleder E, Halttunen J, Dobrilla G, Richter G, Prassler R (1997). "Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer". Lancet. 350 (9079): 692–6. PMID 9291903.
  5. Chung SC, Leong HT, Chan AC, Lau JY, Yung MY, Leung JW, Li AK (1996). "Epinephrine or epinephrine plus alcohol for injection of bleeding ulcers: a prospective randomized trial". Gastrointest. Endosc. 43 (6): 591–5. PMID 8781939.
  6. Scharnke W, Hust MH, Braun B, Schumm W (1997). "[Complete gastric wall necrosis after endoscopic sclerotherapy for a gastric ulcer with visible arterial stump]". Dtsch. Med. Wochenschr. (in German). 122 (19): 606–9. doi:10.1055/s-2008-1047662. PMID 9182025.
  7. 7.0 7.1 Lin HJ, Tseng GY, Perng CL, Lee FY, Chang FY, Lee SD (1999). "Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding". Gut. 44 (5): 715–9. PMC 1727515. PMID 10205211.
  8. Ohta S, Yukioka T, Ohta S, Miyagatani Y, Matsuda H, Shimazaki S (1996). "Hemostasis with endoscopic hemoclipping for severe gastrointestinal bleeding in critically ill patients". Am. J. Gastroenterol. 91 (4): 701–4. PMID 8677932.
  9. Scapa E (1997). "Treating gastrointestinal bleeding with endoscopic hemoclips". Surg Laparosc Endosc. 7 (2): 94–6. PMID 9109234.
  10. Sung JJ, Luo D, Wu JC, Ching JY, Chan FK, Lau JY, Mack S, Ducharme R, Okolo P, Canto M, Kalloo A, Giday SA (2011). "Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding". Endoscopy. 43 (4): 291–5. doi:10.1055/s-0030-1256311. PMID 21455870.
  11. Chiu PW, Lam CY, Lee SW, Kwong KH, Lam SH, Lee DT, Kwok SP (2003). "Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial". Gut. 52 (10): 1403–7. PMC 1773815. PMID 12970130.
  12. Villanueva C, Balanzó J, Torras X, Soriano G, Sáinz S, Vilardell F (1994). "Value of second-look endoscopy after injection therapy for bleeding peptic ulcer: a prospective and randomized trial". Gastrointest. Endosc. 40 (1): 34–9. PMID 8163132.